Prof. Adrian Wolstenholme
LE STUDIUM / Marie Skłodowska-Curie Research Fellow
2nd period : November, 2021 to December, 2021 : LE STUDIUM Guest Research Fellow
From
University of Georgia, Department of Infectious Diseases - USA
In residence at
Infectiology and Public Health (ISP) / Centre INRAE Val de Loire, University of Tours - FR
Host scientist
Dr Cédric Neveu
Project
Further development of caenorhabditis elegans as a tool for studying drug targets in parasitic nematodes
The control of parasitic nematodes impacting both human and animal health relies mainly on the use of anthelmintics. A better knowledge of the molecular targets of these drugs is urgently needed to optimize anthelmintic use and avoid resistance spreading in parasite populations. However, functional validation of anthelmintic targets from parasitic nematodes is difficult because of the lack of efficient transformation tools and the complex lifecycle of these organisms, which require passage through a mammalian host. In order to accelerate these studies we will develop a novel approach to optimize the use of a free-living nematode, Caenorhabditis elegans, as an expression system for genes from parasitic nematodes. In this project, we will use CRISPR/Cas9 to remove C. elegans genes and homology directed repair to insert the parasite sequences into the same locus. Our target genes encode subunits of the glutamate-gated chloride channels and the nicotinic acetylcholine receptors; both families are the targets of widely used anthelmintic drugs, including ivermectin, levamisole and the tetrahydropyrimidines morantel and pyrantel. These families include genes where there are clear parasite and C. elegans equivalents and others where there is no C. elegans ortholog of the parasite gene. We will measure the sensitivity of the recombinant strains to ivermectin, levamisole, pyrantel and morantel, and assess other phenotypic effects of expressing the parasite gene. The phenotypes we will assay include locomotion, egg production and pharyngeal pumping, as these are the processes affected by anthelmintic drugs. These studies will provide new information concerning anthelmintic mode of action and will lay the basis for the extension of such studies to other parasites of animals, plants and humans. It will also provide a paradigm for the investigation of the genetics of other aspects of parasitic nematode biology.
Events organised by this fellow
Publications in relation with the research project
Final reports
The free-living nematode Caenorhabditis elegans has been used for many years as an expression system for genes from parasitic species. We wished to further develop and improve this system by using CRISPR/Cas9 to delete specific genes from C. elegans and replace them with single copies of orthologous genes from the parasite, Haemonchus contortus. Initial experiments focussed on glc-3 which encodes a subunit of the glutamate-gated chloride channels, the target of the avermectin/milbemycin family of anthelmintics. We cloned the promoters from the glc-3 genes of both species and compared the expression patterns of mCherry under the control of both promoters. The C. elegans glc-3 promoter drove expression in a subset of head interneurons, as previously reported whereas the H. contortus promoter drove expression in a pharyngeal motoneuron, M4. We were able to generate heterozygous worms in which one copy of glc-3 was deleted, but we could never obtain homozygous knock-outs. Further investigation of the mRNAs encoded by glc-3 revealed a novel transcript, glc-3T, which encodes a severely truncated form of GLC-3. The presence of such truncated transcripts may explain the unexpected difficulties encountered in attempting to knock out ion channel genes in C. elegans.